Reports Search Total = 1

Sorted by Name

Sorted by Date



Argentina In-vitro Diagnostics Market – Growth, Trends, and Forecast (2019 – 2024)

Healthcare Published by: Mordor Intelligence Market: Argentina
65 pages Published: 01-07-2019
  • Healthcare
  • Mordor Intelligence
  • Argentina
  • 65 pages
  • Published: 01-07-2019

Market Overview


The Argentine IVD market is primarily driven by the high prevalence of chronic diseases. According to the World Heart Federation, non-communicable diseases (NCDs), including CVDs, are estimated to account for 81% of the total adult deaths in Argentina. Among those, CVDs accounts for around 35% of the deaths. Along with that, technological advancements in the country are propelling the growth of the IVD market. As the healthcare expenditure is increasing, the funding for healthcare has been increased, and this is helping the researchers and healthcare professionals to implement the novel technologies in the laboratories. According to the Journal of Cancer Epidemiology & Treatment, around three in every 100 women suffer from breast cancer in Argentina. The rising incidence of this disease is expected to contribute to the growth of the IVD market in the country.


Scope of the Report


As per the scope of this report, in vitro diagnostics involves medical devices and consumables that are utilized to perform in vitro tests on various biological samples. They are used for the diagnosis of various medical conditions, such as chronic diseases. In this report, a detailed analysis of the in vitro diagnostics market is presented, with specific attention toward diabetes and thalassemia. The in vitro diagnostics market has been segmented by technique, product, application, end user, and geography. The segmentation by technique includes POC diagnostics, molecular diagnostics, hematology, tissue diagnostics, microbiology, self-blood glucose monitoring, and other techniques. The segmentation by product includes instruments, consumables, and data management systems. The segmentation by application includes diabetes, cancer (oncology), cardiology, autoimmune disease, nephrology, drug testing, HIV/AIDS, and other applications.


Key Market Trends


Point of Care Diagnostics Segment, by Technique, is Expected to Exhibit Fastest Growth Rate Over the Forecast Period


The point-of-care diagnostics include different products, such as glucose monitoring kits, cardio-metabolic monitoring kits, pregnancy, and fertility testing kits, infectious disease testing kits, cholesterol test strips, and hematology testing kits. Factors, such as the rising prevalence of chronic and infectious diseases in the developing economies, private investments, and venture capital activities supporting R&D of novel products, are expected to boost the market growth. In recent years, several novel technologies, such as biosensors, have been developed, and technologies, like lab-on-a-chip technologies, are paving the way for the development of next-generation point-of-care diagnostic tests. Many new diagnostic tests and immunoassays have received regulatory approvals. For instance, Elecsys HBeAg Immunoassay has been approved by the FDA, which is used to detect human hepatitis B antigen associated with hepatitis B virus infection. The anti-hepatitis C virus infection immunoassay test by Roche Diagnostics is also among several novel products that have been approved by the FDA in recent years. Hence, these technological advancements are expected to drive the POC diagnostics segment in the market studied in the future years.


Competitive Landscape


bioMérieux, Danaher Corporation, Roche Diagnostics, Becton, Dickinson and Company, and Bio-Rad Laboratories Inc. are some of the major players in the market. Major companies are focusing on increasing technological advancements, in order to address customer needs, like fully automated systems, which reduce manual processes and consumables, and also provide fast and accurate results.


Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support


1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study




4.1 Market Overview

4.2 Market Drivers

4.2.1 High Prevalence of Chronic Diseases

4.2.2 Increasing Use of Point-of-care (POC) Diagnostics

4.2.3 Advanced Technologies

4.2.4 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics

4.3 Market Restraints

4.3.1 Stringent Regulations

4.3.2 Cumbersome Reimbursement Procedures

4.4 Porters Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry


5.1 By Technique

5.1.1 Immunochemistry

5.1.2 POC Diagnostics

5.1.3 Molecular Diagnostics

5.1.4 Hematology

5.1.5 Tissue Diagnostics

5.1.6 Microbiology

5.1.7 Self-blood Glucose Monitoring

5.1.8 Other Techniques

5.2 By Product

5.2.1 Instrument

5.2.2 Reagent

5.2.3 Data Management System

5.3 By Usability

5.3.1 Disposable IVD Devices

5.3.2 Reusable IVD Devices

5.4 By Application

5.4.1 Infectious Disease

5.4.2 Diabetes

5.4.3 Cancer/Oncology

5.4.4 Cardiology

5.4.5 Autoimmune Disease

5.4.6 Nephrology

5.4.7 Drug Testing

5.4.8 HIV/AIDS

5.4.9 Other Applications

5.5 End Users

5.5.1 Laboratory

5.5.2 Hospital

5.5.3 Academia

5.5.4 POC Testing

5.5.5 Other End Users


6.1 Company Profiles

6.1.1 Abbott Laboratories

6.1.2 Arkray Inc.

6.1.3 Becton, Dickinson and Company

6.1.4 BioMerieux

6.1.5 Bio-Rad Laboratories Inc.

6.1.6 Danaher Corporation

6.1.7 QIAGEN

6.1.8 Roche Diagnostics

6.1.9 Siemens AG

6.1.10 Thermo Fisher Scientific




By Technique


POC Diagnostics

Molecular Diagnostics


Tissue Diagnostics


Self-blood Glucose Monitoring

Other Techniques


By Product



Data Management System


By Usability

Disposable IVD Devices

Reusable IVD Devices


By Application

Infectious Disease




Autoimmune Disease


Drug Testing


Other Applications


End Users




POC Testing

Other End Users

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type